Clarity Diagnostics LLC CLA-COVFLAB25 WELLlife COVID-19 & Influenza

The CLA-COVFLAB25 WELLlife COVID-19 & Influenza A & B Rapid Test is a reliable and efficient diagnostic tool designed for use in various healthcare settings, including clinics, hospitals, and laboratories. This rapid test kit is particularly useful for quickly identifying COVID-19 and Influenza A & B infections, allowing healthcare professionals to make informed decisions and provide timely care.

The CLA-COVFLAB25 WELLlife COVID-19 & Influenza A & B Rapid Test is intended to detect the presence of SARS-CoV-2, Influenza A, and Influenza B antigens in respiratory specimens. The test utilizes a lateral flow immunoassay technology, which provides rapid and accurate results, enabling healthcare professionals to diagnose and manage patients effectively. This test is an essential tool for healthcare providers, helping to prevent the spread of these infectious diseases and ensuring the well-being of patients.

Key Features

• Simultaneous detection of COVID-19, Influenza A, and Influenza B
• Rapid results in 15 minutes or less
• Highly sensitive and specific lateral flow immunoassay technology
• Easy-to-use test kit with minimal training required
• Individually packaged tests for convenience and reduced waste
• Compatible with a variety of respiratory specimen types
• Clear and concise test results for confident decision-making

Product Specifications

• Dimensions: 5.5 x 3.5 x 2.5 inches per test kit • Weight: 0.5 pounds per test kit • Materials: Plastic, paper, and biological components • Compliance: Meets or exceeds relevant FDA and EUA regulations for COVID-19 and Influenza diagnostic testing

Ideal For

• Hospitals and emergency departments • Clinics and outpatient facilities • Laboratories and research institutions • Home care and telehealth services • Public health organizations and screening programs • Medical offices and physician practices